Albion Financial Group UT held its position in Monsanto Company (NYSE:MON) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,055 shares of the basic materials company’s stock at the end of the 2nd quarter. Albion Financial Group UT’s holdings in Monsanto were worth $243,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in MON. Pinnacle Financial Partners Inc. bought a new stake in shares of Monsanto during the 2nd quarter worth $114,000. Bruderman Asset Management LLC bought a new stake in shares of Monsanto during the 2nd quarter worth $116,000. Tower Research Capital LLC TRC raised its stake in shares of Monsanto by 230.1% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock worth $128,000 after purchasing an additional 750 shares during the period. JNBA Financial Advisors raised its stake in shares of Monsanto by 3.9% during the 1st quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock worth $135,000 after purchasing an additional 45 shares during the period. Finally, Armbruster Capital Management Inc. raised its stake in shares of Monsanto by 12.2% during the 2nd quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock worth $136,000 after purchasing an additional 125 shares during the period. Institutional investors own 74.81% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Albion Financial Group UT Has $243,000 Position in Monsanto Company (MON)” was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this piece of content on another website, it was copied illegally and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://sportsperspectives.com/2017/10/12/albion-financial-group-ut-has-243000-position-in-monsanto-company-mon.html.
In other news, COO Brett D. Begemann sold 22,640 shares of Monsanto stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $120.03, for a total value of $2,717,479.20. Following the completion of the transaction, the chief operating officer now owns 85,439 shares in the company, valued at approximately $10,255,243.17. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Steven Mizell sold 11,526 shares of Monsanto stock in a transaction that occurred on Monday, October 9th. The stock was sold at an average price of $119.70, for a total value of $1,379,662.20. The disclosure for this sale can be found here. In the last quarter, insiders sold 37,026 shares of company stock valued at $4,440,341. Company insiders own 0.79% of the company’s stock.
Shares of Monsanto Company (NYSE:MON) traded up 0.13% during midday trading on Thursday, reaching $119.96. The company had a trading volume of 462,060 shares. The firm has a market capitalization of $52.72 billion, a price-to-earnings ratio of 23.57 and a beta of 1.07. The company has a 50 day moving average of $118.49 and a 200 day moving average of $117.20. Monsanto Company has a 12-month low of $97.35 and a 12-month high of $120.50.
Monsanto (NYSE:MON) last announced its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 EPS for the quarter, topping the Zacks’ consensus estimate of ($0.41) by $0.61. The firm had revenue of $2.69 billion during the quarter, compared to analysts’ expectations of $2.51 billion. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The company’s quarterly revenue was up 4.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.07 EPS. Analysts anticipate that Monsanto Company will post $5.70 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be issued a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.80%. The ex-dividend date of this dividend is Thursday, October 5th. Monsanto’s dividend payout ratio (DPR) is 42.27%.
A number of equities research analysts have recently commented on MON shares. UBS AG cut Monsanto from a “positive” rating to a “neutral” rating in a research note on Tuesday, June 27th. Susquehanna Bancshares Inc reiterated a “neutral” rating and set a $128.00 target price (up from $125.00) on shares of Monsanto in a research note on Tuesday, June 27th. Vetr upgraded Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price on the stock in a research note on Tuesday, June 27th. Royal Bank Of Canada reiterated a “sector perform” rating and set a $128.00 target price (up from $120.00) on shares of Monsanto in a research note on Thursday, June 29th. Finally, Barclays PLC lifted their target price on Monsanto from $115.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Thursday, June 29th. Eleven analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $124.61.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.